<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <title>Fungal Skin Infection (Body & Groin) ‚Äî One‚ÄëPage Algorithm</title>
  <style>
    :root{
      --bg:#f7fafc;
      --paper:#ffffff;
      --ink:#1f2937; /* slate-800 */
      --muted:#6b7280; /* slate-500 */
      --brand:#2563eb; /* blue-600 */
      --brand-2:#10b981; /* emerald-500 */
      --accent:#f59e0b; /* amber-500 */
      --danger:#dc2626; /* red-600 */
      --pill:#e0e7ff; /* indigo-100 */
      --ring:rgba(37, 99, 235, .20);
    }
    *{box-sizing:border-box}
    html,body{height:100%}
    body{
      margin:0; background:var(--bg); color:var(--ink); font:16px/1.5 system-ui, -apple-system, Segoe UI, Roboto, Inter, "Helvetica Neue", Arial, "Noto Sans", "Apple Color Emoji", "Segoe UI Emoji";
    }
    header{
      position:sticky; top:0; z-index:50; backdrop-filter:saturate(180%) blur(8px);
      background:rgba(255,255,255,.85); border-bottom:1px solid #e5e7eb;
    }
    .wrap{max-width:1100px; margin:0 auto; padding:16px 20px}
    .titlebar{display:flex; align-items:center; gap:16px}
    .logo{
      width:44px; height:44px; border-radius:12px; background:linear-gradient(135deg,var(--brand),#60a5fa); display:grid; place-items:center; color:white; font-weight:800; letter-spacing:.5px;
      box-shadow:0 6px 16px rgba(37,99,235,.3);
    }
    h1{font-size:1.35rem; margin:0}
    .actions{margin-left:auto; display:flex; gap:10px}
    button{
      appearance:none; border:1px solid #e5e7eb; background:var(--paper); color:var(--ink);
      padding:10px 14px; border-radius:10px; cursor:pointer; font-weight:600;
    }
    button.primary{background:var(--brand); color:#fff; border-color:transparent}
    button:hover{box-shadow:0 3px 12px rgba(0,0,0,.07)}

    main{padding:24px 0 64px}

    /* hero */
    .hero{display:grid; grid-template-columns:1.2fr .8fr; gap:18px; align-items:stretch}
    .card{
      background:var(--paper); border:1px solid #e5e7eb; border-radius:16px; padding:18px; box-shadow:0 6px 24px rgba(0,0,0,.05);
    }
    .badge{display:inline-flex; gap:8px; align-items:center; background:var(--pill); color:#3730a3; font-weight:700; padding:6px 10px; border-radius:999px; font-size:.8rem}
    .sub{color:var(--muted); font-size:.95rem}

    .two-col{display:grid; grid-template-columns:1fr 1fr; gap:16px}
    .grid{display:grid; gap:16px}
    .grid-3{grid-template-columns:repeat(3,1fr)}

    h2{margin:.1rem 0 10px; font-size:1.1rem}
    h3{margin:12px 0 6px; font-size:1rem}
    .list{margin:0; padding-left:18px}
    .list li{margin:4px 0}

    /* stepper */
    .stepper{display:grid; grid-template-columns: 40px 1fr; gap:14px}
    .step{
      position:relative; padding-bottom:8px
    }
    .dot{
      width:28px; height:28px; border-radius:999px; background:var(--paper); border:2px solid var(--brand); display:grid; place-items:center; font-weight:800; color:var(--brand);
      box-shadow:0 4px 10px var(--ring);
    }
    .step:after{content:""; position:absolute; left:12px; top:34px; bottom:-8px; width:4px; background:linear-gradient(var(--brand),transparent)}
    .step:last-child:after{display:none}

    /* pills */
    .pill{display:inline-block; padding:4px 10px; border-radius:999px; background:#ecfeff; color:#155e75; border:1px solid #cffafe; font-weight:700; font-size:.8rem}
    .warn{background:#fff7ed; color:#9a3412; border-color:#fed7aa}
    .danger{background:#fee2e2; color:#7f1d1d; border-color:#fecaca}
    .ok{background:#ecfdf5; color:#065f46; border-color:#bbf7d0}

    /* tables */
    table{width:100%; border-collapse:separate; border-spacing:0; overflow:hidden; border-radius:12px; border:1px solid #e5e7eb}
    thead th{background:#f3f4f6; text-align:left; padding:10px; font-size:.9rem}
    td{padding:10px; border-top:1px solid #e5e7eb; vertical-align:top}

    /* callouts */
    .callout{display:flex; gap:12px; align-items:flex-start; border-left:6px solid var(--brand); background:#eff6ff; padding:12px 14px; border-radius:10px}
    .callout .ico{font-weight:900; color:var(--brand)}

    /* footer */
    footer{color:var(--muted); font-size:.85rem; margin-top:18px}

    /* print */
    @media print{
      header, .actions{display:none!important}
      body{background:white}
      .card{box-shadow:none; border:1px solid #ddd}
      main{padding:0}
    }

    @media (max-width:900px){
      .hero{grid-template-columns:1fr}
      .two-col{grid-template-columns:1fr}
      .grid-3{grid-template-columns:1fr}
    }
  </style>
</head>
<body>
  <header>
    <div class="wrap titlebar">
      <div class="logo" aria-hidden="true">Fx</div>
      <div>
        <h1>Fungal Skin Infection ‚Äî Body & Groin (Tinea corporis, Tinea cruris)</h1>
        <div class="sub">One‚Äëpage decision aide for fast consultations (‚â•1 month of age). Light theme for printing.</div>
      </div>
      <div class="actions">
        <button onclick="window.print()" class="primary" title="Print or save as PDF">Print / Save PDF</button>
        <button onclick="toggleCompact()" title="Toggle compact layout">Compact</button>
      </div>
    </div>
  </header>

  <main class="wrap grid">

    <section class="hero">
      <article class="card">
        <span class="badge" title="When to think fungal?">CLINICAL SUSPICION</span>
        <div class="grid two-col" style="margin-top:10px">
          <div>
            <h2>Body (Tinea corporis)</h2>
            <ul class="list">
              <li>Annular, scaly, itchy patches (1‚Äì5 cm), enlarging outward.</li>
              <li>Active red scaly edge with central clearing; often asymmetric; may coalesce.</li>
              <li>Variants: concentric circles (imbricate), vesicles/pustules (bullous).</li>
            </ul>
          </div>
          <div>
            <h2>Groin (Tinea cruris)</h2>
            <ul class="list">
              <li>Inguinal folds & proximal medial thighs; buttocks/above waist may be involved.</li>
              <li>Red to red‚Äëbrown plaques with active borders; scale uniform; central clearing may be absent in moist flexures.</li>
              <li>Scrotum/penis usually spared.</li>
            </ul>
          </div>
        </div>
      </article>
      <aside class="card">
        <h2>Quick Facts</h2>
        <ul class="list">
          <li><span class="pill ok">Main pathogens</span> Dermatophytes (e.g., <em>Trichophyton rubrum</em>, <em>T. interdigitale</em>).</li>
          <li><span class="pill">Transmission</span> Direct contact (human/animal), fomites; less often soil.</li>
          <li><span class="pill">Risk factors</span> Humidity/heat, tight clothing, obesity, hyperhidrosis, immunosuppression.</li>
          <li><span class="pill">Complications</span> Tinea incognito, Majocchi granuloma, secondary bacterial infection.</li>
        </ul>
        <div class="callout" style="margin-top:10px">
          <div class="ico">‚ö†Ô∏è</div>
          <div><strong>Avoid topical steroid monotherapy.</strong> If used, limit to mild potency (hydrocortisone 1%) for ‚â§7 days <em>with</em> antifungal when inflammation is marked. Never if tinea incognito suspected.</div>
        </div>
      </aside>
    </section>

    <section class="card">
      <span class="badge">ASSESSMENT & TESTING</span>
      <div class="stepper" style="margin-top:10px">
        <div class="step"><div class="dot">1</div></div>
        <div>
          <h3>History & Exam</h3>
          <ul class="list">
            <li>Symptoms: itch, scale; site/duration; OTC treatments; contacts; comorbidities.</li>
            <li>Extent/severity; other fungal sites (feet, nails, hands); steroid overuse signs.</li>
          </ul>
        </div>
        <div class="step"><div class="dot">2</div></div>
        <div>
          <h3>When to sample (skin scrapings for microscopy & culture)</h3>
          <ul class="list">
            <li>Severe or extensive disease (adults), atypical/uncertain Dx, immunocompromised, or poor response.</li>
            <li>Scrape advancing edge; ‚â•5 mm¬≤ scale into paper packet; keep at room temp (no fridge).</li>
            <li>Microscopy 1‚Äì2 days; culture 2‚Äì3 weeks. Consider swab if very pustular/macerated.</li>
          </ul>
        </div>
      </div>
    </section>

    <section class="card">
      <span class="badge">DIFFERENTIAL DIAGNOSIS</span>
      <div class="two-col" style="margin-top:10px">
        <ul class="list">
          <li>Discoid eczema</li>
          <li>Pityriasis rosea</li>
          <li>Pityriasis versicolor</li>
          <li>Psoriasis (incl. flexural)</li>
        </ul>
        <ul class="list">
          <li>Granuloma annulare</li>
          <li>Intertrigo / Candida</li>
          <li>Erythrasma</li>
          <li>Seborrhoeic dermatitis; SCLE; EM</li>
        </ul>
      </div>
    </section>

    <section class="card">
      <span class="badge">MANAGEMENT ALGORITHM</span>
      <div class="grid" style="margin-top:10px">
        <div class="callout">
          <div class="ico">üí°</div>
          <div><strong>Self‚Äëcare for all:</strong> Loose cotton/tech fabrics; daily wash & thorough drying (esp. folds); avoid scratching; don‚Äôt share towels; wash towels/linen & clothes frequently. Children: no school/nursery exclusion.</div>
        </div>

        <div class="two-col">
          <div>
            <h3>1) Mild, non‚Äëextensive disease (adults & children)</h3>
            <table aria-label="Topical antifungals dosing">
              <thead>
                <tr><th>Topical option</th><th>How to use</th></tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Terbinafine 1% cream</strong> (‚â•12y)</td>
                  <td>Thin layer OD‚ÄìBD for 1‚Äì2 weeks.</td>
                </tr>
                <tr>
                  <td><strong>Clotrimazole 1% cream</strong></td>
                  <td>Apply 2‚Äì3√ó/day ‚â•4 weeks. ~0.5 cm strip treats palm‚Äësized area.</td>
                </tr>
                <tr>
                  <td><strong>Miconazole 2% cream</strong></td>
                  <td>Apply BD, continue 10 days after lesions heal.</td>
                </tr>
                <tr>
                  <td><strong>Econazole 1% cream</strong></td>
                  <td>Apply BD until lesions heal.</td>
                </tr>
              </tbody>
            </table>
            <p style="margin:.6rem 0 0"><span class="pill warn">If marked inflammation</span> add <strong>Hydrocortisone 1% OD</strong> for ‚â§7 days (never alone).</p>
            <p class="sub">May repeat topical course for future mild recurrences if previously effective.</p>
          </div>
          <div>
            <h3>2) Severe or extensive disease (adults)</h3>
            <p>Start oral therapy if: positive mycology, strong clinical suspicion while awaiting results, or negative mycology with highly suggestive features (repeat sampling).</p>
            <table aria-label="Oral antifungals dosing">
              <thead>
                <tr><th>Oral option</th><th>Adult dosing</th><th>Typical duration</th></tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Terbinafine</strong></td>
                  <td>250 mg once daily</td>
                  <td>Body: 4 wks ‚Ä¢ Groin: 2‚Äì4 wks</td>
                </tr>
                <tr>
                  <td><strong>Itraconazole</strong></td>
                  <td>100 mg OD √ó15 d <em>or</em> 200 mg OD √ó7 d</td>
                  <td>Per course</td>
                </tr>
                <tr>
                  <td><strong>Griseofulvin</strong></td>
                  <td>500‚Äì1000 mg daily; reduce once responding</td>
                  <td>‚â•4 wks; continue ‚â•2 wks after healing</td>
                </tr>
              </tbody>
            </table>
            <p class="sub"><span class="pill danger">Children with severe/extensive</span> ‚Üí refer paediatric dermatology.</p>
          </div>
        </div>
      </div>
    </section>

    <section class="card">
      <span class="badge">FOLLOW‚ÄëUP ‚Ä¢ FAILURE ‚Ä¢ REFERRAL</span>
      <div class="two-col" style="margin-top:10px">
        <div>
          <h3>Review if inadequate response</h3>
          <ul class="list">
            <li>Adherence (self‚Äëcare, application, duration).</li>
            <li>Steroid misuse ‚Üí tinea incognito.</li>
            <li>Re‚Äëexposure/reinfection (contacts, fomites).</li>
            <li>Multiple/drug‚Äëresistant organisms.</li>
            <li>Drug interactions/adverse effects.</li>
            <li>Immunocompromised host.</li>
            <li>Alternative diagnosis.</li>
          </ul>
          <p>Arrange mycology; consider switching to oral therapy per clinical judgement.</p>
        </div>
        <div>
          <h3>Refer to Dermatology</h3>
          <ul class="list">
            <li>Severe/extensive disease (any age); child not responding to topical therapy.</li>
            <li>Uncertain diagnosis; frequent recurrences.</li>
            <li>Immunocompromised or treatment failure in primary care.</li>
          </ul>
        </div>
      </div>
    </section>

    <section class="card">
      <span class="badge">SAFETY & INTERACTIONS (Oral agents)</span>
      <div class="grid grid-3" style="margin-top:10px">
        <div>
          <h3>Terbinafine</h3>
          <ul class="list">
            <li><span class="pill danger">Avoid</span> chronic/active liver disease; severe renal impairment.</li>
            <li><strong>LFTs</strong> baseline & at 4‚Äì6 wks; stop if symptoms or abnormal.</li>
            <li>Notable interactions: ‚Üìcodeine effect; ‚Üëlevels with azoles/amiodarone; ‚Üëlevels of many Œ≤‚Äëblockers, TCA, SSRI, anti‚Äëarrhythmics, etc.</li>
            <li>Warn: hepatotoxicity symptoms; rash/SJS (rare); taste disturbance.</li>
          </ul>
        </div>
        <div>
          <h3>Itraconazole</h3>
          <ul class="list">
            <li><span class="pill danger">Contraindicated</span> in ventricular dysfunction/HF; acute porphyria.</li>
            <li>Caution: liver disease (monitor), renal impairment, immunocompromised.</li>
            <li>Potent CYP3A4 interactions (‚Üëmany drugs incl. CCB, benzodiazepines, statins; QT‚Äëprolongation risks).</li>
          </ul>
        </div>
        <div>
          <h3>Griseofulvin</h3>
          <ul class="list">
            <li><span class="pill danger">Avoid</span> severe liver disease, SLE, acute porphyria.</li>
            <li>Interactions: alcohol (disulfiram‚Äëlike), ‚ÜìOCP efficacy (use alternative), warfarin (‚ÜìINR), enzyme inducers.</li>
            <li>Take after high‚Äëfat meal; may impair skilled tasks.</li>
          </ul>
        </div>
      </div>
    </section>

    <footer class="wrap sub">
      Designed as a compact clinical aide. Content condensed from your provided guidance (NICE CKS, last major review July¬†2023). This page is not a substitute for full prescribing information.
    </footer>
  </main>

  <script>
    function toggleCompact(){
      document.body.classList.toggle('compact');
      const compact = document.body.classList.contains('compact');
      document.querySelectorAll('.card').forEach(el=>{
        el.style.padding = compact ? '14px' : '18px';
      });
      document.querySelectorAll('.list li').forEach(li=>{
        li.style.margin = compact ? '2px 0' : '4px 0';
      });
    }
  </script>
</body>
</html>
